Document Detail

Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study).
MedLine Citation:
PMID:  8184807     Owner:  NLM     Status:  MEDLINE    
The effect of late percutaneous transluminal coronary angioplasty (PTCA) of an occluded infarct-related artery on left ventricular ejection fraction was studied in patients with a recent, first Q-wave myocardial infarction in a prospective, randomized study. Forty-four patients (31 men and 13 women, mean age 58 +/- 12 years) with an occluded infarct-related coronary artery were randomized to PTCA (n = 25) or no PTCA (n = 19). Patients received acetylsalicylic acid, a beta blocker and an angiotensin-converting enzyme inhibitor unless contraindicated. Left ventricular ejection fraction was determined at baseline and 4 months. Coronary angiography was repeated at 4 months. Baseline ejection fraction measured 20 +/- 12 days after myocardial infarction was 45 +/- 12% in both groups. PTCA was performed 21 +/- 13 days after the event. The primary PTCA success rate was 72%. One patient in each group died before angiographic follow-up, which was completed in 37 of the remaining 42 patients (88%; 21 with and 16 without PTCA). At 4 months, the infarct-related artery was patent in 43% of PTCA patients and in 19% of no PTCA patients (p = NS). Reocclusion occurred in 40% of patients after successful PTCA. Secondary analyses showed that the change in left ventricular ejection fraction was significantly greater in patients with a patent infarct-related artery (+9.4 +/- 6.2%) than in those with an occluded artery (+1.6 +/- 8.8%; p = 0.0096). Baseline ejection fraction also independently predicted improvement in left ventricular ejection fraction (p = 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)
V Dzavik; D S Beanlands; R F Davies; D Leddy; J F Marquis; K K Teo; T D Ruddy; J R Burton; D P Humen
Related Documents :
2516807 - Bilateral mammary artery surgery or percutaneous transluminal coronary angioplasty for ...
2951907 - Percutaneous transluminal coronary angioplasty.
10443757 - Cognitive adaptation as a predictor of new coronary events after percutaneous translumi...
10146597 - Percutaneous transluminal coronary angioplasty for chronic dialysis patients.
7200367 - Hypertrophic cardiomyopathy without asymmetric hypertrophy.
10567287 - Five-year follow-op of the medicine, angioplasty, or surgery study (mass): a prospectiv...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of cardiology     Volume:  73     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-06-16     Completed Date:  1994-06-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  856-61     Citation Subset:  AIM; IM    
University of Ottawa Heart Institute, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Coronary Angiography
Coronary Circulation
Coronary Disease / physiopathology*,  therapy
Middle Aged
Myocardial Infarction / physiopathology*,  therapy
Pilot Projects
Time Factors
Ventricular Function, Left*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Additional ST-segment elevation immediately after reperfusion and its effect on myocardial salvage i...
Next Document:  Clinical significance of pericardial effusion in Q-wave inferior wall acute myocardial infarction.